B cell characterization and reactivity analysis in multiple sclerosis

Autoimmunity Reviews

Volumn 8, Issue 8, 2009, Pages 654-658

  Fraussen, J ^a   Vrolix, K ^b   Martinez Martinez, P ^b   Losen, M ^b   De Baets, M H ^a,b   Stinissen, P ^a   Somers, V ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Antibodies; Antibody secreting cells; B cells; Cerebrospinal fluid; Multiple sclerosis

Indexed keywords

ANTIBODY; AUTOANTIBODY; IMMUNOGLOBULIN G; MYELIN; OLIGOCLONAL BAND;

ANTIBODY PRODUCTION; B LYMPHOCYTE; CELL IMMORTALIZATION; CEREBROSPINAL FLUID; EPSTEIN BARR VIRUS; HUMAN; LYMPHOCYTE SUBPOPULATION; MACROGLIA; MEMORY CELL; MULTIPLE SCLEROSIS; NERVE FIBER; PLASMA CELL; REVIEW;

ASTROCYTES; AUTOANTIBODIES; AUTOANTIGENS; AXONS; B-LYMPHOCYTE SUBSETS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGOCLONAL BANDS; PLASMA CELLS;

EID: 67349160792     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.02.030     Document Type: Review

References (37)

1. Kabat E.A., Glusman M., and Knaub V. Quantitative estimation of the albumin and gamma-globulin in normal and pathological cerebrospinal fluid by immunochemical methods. Am J Med 4 (1948) 653-662
2. Cross A.H., Trotter J.L., and Lyons J. B cells and antibodies in CNS demyelinating disease. J. Neuroimmunol. 112 1-2 (2001) 1-14
3. Archelos J.J., Storch M.K., and Hartung H.P. The role of B cells and autoantibodies in multiple sclerosis. Ann. Neurol. 47 6 (2000) 694-706
4. Ziemssen T., and Ziemssen F. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). Autoimmun. Rev. 4 7 (2005) 460-467
5. Baranzini S.E., Jeong M.C., Butunoi C., Murray R.S., Bernard C.C., and Oksenberg J.R. B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J. Immunol. 163 9 (1999) 5133-5144
6. Colombo M., Dono M., Gazzola P., Roncella S., Valetto A., Chiorazzi N., et al. Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J. Immunol. 164 5 (2000) 2782-2789
7. Qin Y., and Duquette P. B-cell immunity in MS. Int. MS J. 10 4 (2003) 110-120
8. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., and Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 14 2 (2004) 164-174
9. Bar-Or A., Calabresi P.A., Arnold D., Markowitz C., Shafer S., Kasper L.H., et al. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann. Neurol. 63 3 (2008) 395-400
10. Hauser S.L., Waubant E., Arnold D.L., Vollmer T., Antel J., Fox R.J., et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358 7 (2008) 676-688
11. Youinou P., Hillion S., Jamin C., Pers J.O., Saraux A., and Renaudineau Y. B lymphocytes on the front line of autoimmunity. Autoimmun. Rev. 5 3 (2006) 215-221
12. Meinl E., Krumbholz M., and Hohlfeld R. B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation. Ann. Neurol. 59 6 (2006) 880-892
13. Le Pottier L., Devauchelle V., Pers J.O., Jamin C., and Youinou P. The mosaic of B-cell subsets (with special emphasis on primary Sjogren's syndrome). Autoimmun. Rev. 6 3 (2007) 149-154
14. Cepok S., Rosche B., Grummel V., Vogel F., Zhou D., Sayn J., et al. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 128 Pt 7 (2005) 1667-1676
15. Corcione A., Casazza S., Ferretti E., Giunti D., Zappia E., Pistorio A., et al. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 101 30 (2004) 11064-11069
16. Corcione A., Aloisi F., Serafini B., Capello E., Mancardi G.L., Pistoia V., et al. B-cell differentiation in the CNS of patients with multiple sclerosis. Autoimmun. Rev. 4 8 (2005) 549-554
17. Ritchie A.M., Gilden D.H., Williamson R.A., Burgoon M.P., Yu X., Helm K., et al. Comparative analysis of the CD19+ and CD138+ cell antibody repertoires in the cerebrospinal fluid of patients with multiple sclerosis. J. Immunol. 173 1 (2004) 649-656
18. Kuenz B., Lutterotti A., Ehling R., Gneiss C., Haemmerle M., Rainer C., et al. Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PLoS.ONE. 3 7 (2008) e2559
19. Pascual V., Liu Y.J., Magalski A., de Bouteiller O., Banchereau J., and Capra J.D. Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp. Med. 180 1 (1994) 329-339
20. Winges K.M., Gilden D.H., Bennett J.L., Yu X., Ritchie A.M., and Owens G.P. Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blasts. J. Neuroimmunol. 192 1-2 (2007) 226-234
21. Jego G., Robillard N., Puthier D., Amiot M., Accard F., Pineau D., et al. Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells. Blood 94 2 (1999) 701-712
22. Cepok S., Jacobsen M., Schock S., Omer B., Jaekel S., Boddeker I., et al. Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain 124 Pt 11 (2001) 2169-2176
23. Reindl M., Khalil M., and Berger T. Antibodies as biological markers for pathophysiological processes in MS. J. Neuroimmunol. 180 1-2 (2006) 50-62
24. Link H., Baig S., Jiang Y.P., Olsson O., Hojeberg B., Kostulas V., et al. B cells and antibodies in MS. Res. Immunol. 140 2 (1989) 219-226
25. Sun J., Link H., Olsson T., Xiao B.G., Andersson G., Ekre H.P., et al. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146 5 (1991) 1490-1495
26. Lambracht-Washington D., O'connor K.C., Cameron E.M., Jowdry A., Ward E.S., Frohman E., et al. Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS. J. Neuroimmunol. (2007)
27. von Budingen H.C., Harrer M.D., Kuenzle S., Meier M., and Goebels N. Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies. Eur. J. Immunol. 38 7 (2008) 2014-2023
28. Zhang Y., Da R.R., Guo W., Ren H.M., Hilgenberg L.G., Sobel R.A., et al. Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis. J. Clin. Immunol. 25 3 (2005) 254-264
29. Kolln J., Ren H.M., Da R.R., Zhang Y., Spillner E., Olek M., et al. Triosephosphate isomerase- and glyceraldehyde-3-phosphate dehydrogenase-reactive autoantibodies in the cerebrospinal fluid of patients with multiple sclerosis. J. Immunol. 177 8 (2006) 5652-5658
30. Rosen A., Gergely P., Jondal M., Klein G., and Britton S. Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature 267 5606 (1977) 52-54
31. Steinitz M., Klein G., Koskimies S., and Makel O. EB virus-induced B lymphocyte cell lines producing specific antibody. Nature 269 5627 (1977) 420-422
32. Kozbor D., Roder J.C., Chang T.H., Steplewski Z., and Koprowski H. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma. Hybridoma 1 3 (1982) 323-328
33. Bron D., Feinberg M.B., Teng N.N., and Kaplan H.S. Production of human monoclonal IgG antibodies against Rhesus (D) antigen. Proc. Natl. Acad. Sci. U.S.A 81 10 (1984) 3214-3217
34. Ifversen P., Zhang X.M., Ohlin M., Zeuthen J., and Borrebaeck C.A. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines. Hum. Antibodies Hybridomas 4 3 (1993) 115-123
35. Traggiai E., Becker S., Subbarao K., Kolesnikova L., Uematsu Y., Gismondo M.R., et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 10 8 (2004) 871-875
36. Hurst J., and von Landenberg P. Toll-like receptors and autoimmunity. Autoimmun. Rev. 7 3 (2008) 204-208
37. van Dongen J.J., Langerak A.W., Bruggemann M., Evans P.A., Hummel M., Lavender F.L., et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17 12 (2003) 2257-2317